We Offer Worldwide Shipping
Login Wishlist

5-Amino-1,3-dihydro-2H-benzimidazol-2-one

$64

  • Brand : BIOFRON

  • Catalogue Number : BN-O1060

  • Specification : 99%(HPLC)

  • CAS number : 95-23-8

  • Formula : C7H7N3O

  • Molecular Weight : 149.15

  • PUBCHEM ID : 66765

  • Volume : 5mg

Available on backorder

Quantity
Checkout Bulk Order?

Catalogue Number

BN-O1060

Analysis Method

Specification

99%(HPLC)

Storage

2-8°C

Molecular Weight

149.15

Appearance

Botanical Source

Structure Type

Category

SMILES

C1=CC2=C(C=C1N)NC(=O)N2

Synonyms

5(6)-Aminobenzoimidazolone/5-AMINO-6-CHLOROBENZOIMINDAZOLONE/5-Amino-1,3-dihydro-2H-benzimidazol-2-one/2H-Benzimidazol-2-one, 5-amino-1,3-dihydro-/5-Amino-2-benzimidazolinon/2H-BENZIMIDAZOL-2-ONE,5-AMINO-1,3-DIHYDRO-/5-AMINOBENZOIMIDAZOLONE/5-AMINOBENZIMIDAZOLINONE/5-AMINO BENZIMIDAZOLONE/5-AMINOBENZIMIDAZOLONE/5-Amino-1,3-dihydrobenzoimidazol-2-one/5-AMINOBENZIMIDAZOLIDINONE/5-AMINO-1,3-DIHYDRO-BENZOIMIDAZOL-2-ONE

IUPAC Name

5-amino-1,3-dihydrobenzimidazol-2-one

Density

1.4±0.1 g/cm3

Solubility

Flash Point

75.6±21.5 °C

Boiling Point

201.4±19.0 °C at 760 mmHg

Melting Point

InChl

InChl Key

BCXSVFBDMPSKPT-UHFFFAOYSA-N

WGK Germany

RID/ADR

HS Code Reference

Personal Projective Equipment

Correct Usage

For Reference Standard and R&D, Not for Human Use Directly.

Meta Tag

provides coniferyl ferulate(CAS#:95-23-8) MSDS, density, melting point, boiling point, structure, formula, molecular weight etc. Articles of coniferyl ferulate are included as well.>> amp version: coniferyl ferulate

No Technical Documents Available For This Product.

PMID

31886070

Abstract

Introduction

Human papillomavirus (HPV) is the most common infection of the reproductive tract. The introduction of HPV vaccines by WHO aims to reduce the incidence of cervical cancer. Pakistan lacks an effective nationwide HPV vaccination program, thereby making HPV a major threat. In this study, we aimed to assess the knowledge of HPV vaccination in Pakistan and to determine the barriers against it.

Methods

A cross-sectional study was conducted in Karachi, Pakistan, between April and May 2019. A convenience sampling technique was implemented using a self-administered questionnaire, which was filled by individuals aged 18-26. The questionnaire assessed the knowledge regarding HPV and also evaluated the attitude and acceptability amongst these individuals towards the vaccine. Data were analyzed using Statistical Package for Social Sciences (SPSS), version 20.0.

Results

The majority of the participants belonged to the monthly household income range of 200,000 rupees and above, which was labeled as the high-income category (n=158, 39.5%). Out of the 18 people who were vaccinated, eight belonged to the aforementioned category. Of these 18, nearly two-thirds (n=11, 61.1%) had gotten vaccinated upon the recommendation of their doctor. A statistically significant difference was found only between those currently enrolled in universities and previously vaccinated for HPV (p=.047). Nearly half of the responders perceived the vaccine to be time-consuming (n=167, 41.8%) and overpriced (n=187, 46.8%).

Conclusion

The vaccination rate is low in Karachi, Pakistan. Concentrated efforts involving the healthcare system should be made to raise awareness regarding HPV and its vaccine thereby reducing barriers to HPV prevention

KEYWORDS

human papilloma virus (hpv), knowledge, attitude, barriers, vaccine, youth, karachi, pakistan

Title

Knowledge, Attitude, and Barriers Towards Human Papillomavirus (HPV) Vaccination Among Youths of Karachi, Pakistan Monitoring Editor: Alexander Muacevic and John R Adler

Author

Mahnoor Y Shaikh,corresponding author1 Maheen F Hussaini,1 Mehek Narmeen,1 Rida Effendi,1 Neha S Paryani,1 Ameer Ahmed,1 Muhammad Khan,1 and Hasan Obaid2

Publish date

2019 Nov


Description :

Empty ...